Lv32
220 积分 2024-10-07 加入
Clinical Grade Manufacture of CYAD-101, a NKG2D-based, First in Class, Non–Gene-edited Allogeneic CAR T-Cell Therapy
4天前
已完结
Intracellular Retention of Tcrαβ/CD3 to Generate Novel Allogeneic CAR-T Cells (ThisCART19A) with Enhanced Antitumor Potency for Treating B-ALL
4天前
已关闭
Intracellular Retention of Tcrαβ/CD3 to Generate Novel Allogeneic CAR-T Cells (ThisCART19A) with Enhanced Antitumor Potency for Treating B-ALL
4天前
已关闭
Allogeneic CD19-targeted CAR-T therapy in patients with severe myositis and systemic sclerosis
12天前
已关闭
Inhibition of intrarenal PRR-RAS pathway by Ganoderma lucidum polysaccharide peptides in proteinuric nephropathy
21天前
已完结
Extracellular Vesicles-Hitchhiking Boosts the Deep Penetration of Drugs to Amplify Anti-Tumor Efficacy
1个月前
已完结
皖公网安备34019202002308
